Source: Eur Respir J 2016; 47:1357-1364
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vutcovici Maria, Bitton Alain, Ernst Pierre, Kezouh Abbas, Suissa Samy, Brassard Paul. Inflammatory bowel disease and risk of mortality in COPD. Eur Respir J 2016; 47:1357-1364

Member's Comments

No comment yet.

Related content which might interest you: Inflammatory bowel diseases in COPD patients. Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Chronic asthma and the risk of cardiovascular disease Source: Eur Respir Monogr 2020; 88: 82-95 Year: 2020 Exacerbations and mortality of COPD patients with cardiovascular disease in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Functional and inflammatory bowel diseases in patients with COPD Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 Increased incidence of inflammatory bowel disease in Québec residents with airway diseases Source: Eur Respir J 2015; 45: 962-968 Year: 2015 Morbidity and mortality in patients with chronic obstructive pulmonary disease and cachexia Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Anaemia in COPD: mortality and disease severity Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Mortality in COPD: role of comorbidities Source: Eur Respir J 2006; 28: 1245-1257 Year: 2006 Cardiovascular risk factors in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation Source: Annual Congress 2013 –The latest insights in chronic care Year: 2013 Risk factors for mortality in patients with COPD exacerbation Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype Source: International Congress 2016 – Monitoring comorbidities Year: 2016